Invasive breast carcinoma - IARC
Invasive breast carcinoma - IARC
Invasive breast carcinoma - IARC
Create successful ePaper yourself
Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.
Clinical features<br />
M o re than 70% of the tumours are unilateral.<br />
The age range is 11-76 years<br />
with the majority of tumours occurring<br />
a round the 5th and 6th decade. The<br />
clinical symptoms do not differ fro m<br />
those recognized for other ovarian<br />
tumours.<br />
M a c r o s c o p y<br />
Most tumours are solid and firm, but<br />
some may show variably sized cysts,<br />
sometimes filled with mucoid or haemorrhagic<br />
fluid or debris. The sectioned<br />
s u rface appears yellow-white or tan,<br />
sometimes interspersed with gre y<br />
f i b rous bundles or septa.<br />
Fig. 2.36 Endometrioid borderline tumour. Whereas most endometrioid borderline tumours have an adenofibromatous<br />
appearance, the adenofibromatous lesion is rarely evident within a large cystic mass.<br />
overlying a dominant sarcomatous mesenchyme.<br />
Clinical features<br />
Most of the tumours reported so far have<br />
been unilateral, occurring in the 4th and<br />
5th decades. Abdominal discomfort and<br />
distension are the usual complaints.<br />
Macroscopy and histopathology<br />
The tumour is frequently adherent to the<br />
s u r rounding tissue {512,604,929}. The<br />
macroscopic and histological features<br />
are described in detail in the uterine<br />
counterpart (see chapter 4).<br />
Prognosis and predictive factors<br />
Occasional re p o rts have linked the<br />
s p read of adenosarcomas into the<br />
abdominal cavity with a poor clinical<br />
outcome {510}. The stroma is often predominantly<br />
fibrotic, oedematous or hyalized<br />
with characteristic foci of perivascular<br />
cuffing seen only focally (sometimes,<br />
the foci are very small) and still<br />
the tumours recur and kill the patient<br />
{760}. Unfort u n a t e l y, there exist no<br />
established morphological criteria to<br />
p redict such biological behaviour. Howe<br />
v e r, if during the course of the disease<br />
s a rcomatous overgrowth develops, signifying<br />
invasive potential, the patient<br />
re q u i res careful monitoring. In a series<br />
of 40 cases, the 5-year survival was<br />
64%, the 10-year survival 46% and the<br />
15-year survival 30% {760}. Age gre a t e r<br />
than 53 years, tumour rupture, high<br />
grade and the presence of high grade<br />
s a rcomatous overgrowth appear to be<br />
associated with re c u r rence or extraovarian<br />
spread. Ovarian adenosarcoma has<br />
a worse prognosis than its uterine count<br />
e r p a rt, presumably because of the<br />
g reater ease of peritoneal spread {760}.<br />
T h e r a p e u t i c a l l y, an aggressive surgical<br />
a p p roach with wide excision is most<br />
often recommended {510}. Chemotherapy<br />
and radiation may be applied in<br />
individual cases; however, no established<br />
protocols exist.<br />
Endometrioid stromal and<br />
undifferentiated ovarian sarcoma<br />
Definition<br />
Endometrioid stromal sarcoma (ESS) is<br />
a monophasic sarcomatous tumour<br />
characterized by a diffuse pro l i f e r a t i o n<br />
of neoplastic cells similar to stro m a l<br />
cells of proliferative endometrium. At its<br />
p e r i p h e ry the tumour exhibits a typical<br />
infiltrative growth pattern. Those neoplasms<br />
that have moderate to marked<br />
pleomorphism, significant nuclear anaplasia<br />
and more cytoplasm than is<br />
found in endometrial stromal cells<br />
should be classified as undiff e re n t i a t e d<br />
ovarian sarc o m a .<br />
Histopathology<br />
Roughly half of the cases of ESS are<br />
associated with either endometriosis or a<br />
similar sarcomatous lesion of the<br />
endometrial stroma or both {2605}. The<br />
dominant cell type of ESS consists of<br />
small, round to oval, or occasionally spindle<br />
shaped cells with round nuclei and<br />
scanty, sometimes barely visible pale<br />
cytoplasm. The cells may be arranged<br />
haphazardly in a diffuse pattern or may<br />
form parallel cell sheets mimicking fibroma.<br />
Hypocellular areas with a distinct<br />
oedematous appearance can be present.<br />
Lipid droplets may be present within<br />
tumour cells, which are often associated<br />
with foam cells. A hallmark of ESS is the<br />
presence of abundant small thick-walled<br />
vessels resembling spiral arteries of the<br />
late secretory endometrium. The vessels<br />
often are surrounded by whorls of neoplastic<br />
cells. Reticulin stain discloses<br />
delicate fibrils characteristically enveloping<br />
individual tumour cells. The cellularity<br />
can vary markedly within the same<br />
specimen. The tumour can be partly<br />
intersected by fibrous bands form i n g<br />
more or less distinct nodules. Sometimes,<br />
hyaline plaques are pre s e n t .<br />
Rarely, cord-like or plexiform arrangements<br />
of tumour cells similar to the<br />
growth patterns seen in ovarian sex cord<br />
tumours such as granulosa cell tumours<br />
or thecomas are observed. In these<br />
areas reticulin fibrils are more or less<br />
absent. Rarely, glandular elements are<br />
interspersed, but they never represent a<br />
dominant feature. At its periphery the<br />
tumour exhibits a typical infiltrative<br />
g rowth pattern. In cases where the<br />
tumour has spread into extraovarian<br />
sites, a tongue-like pattern of invasion<br />
134 Tumours of the ovary and peritoneum